Innovation Pharmaceuticals At Digestive Disease Week Conference, Nears Selecting Drug Formulation Company to Prepare Oral Brilacidin for Targeted Delivery in Ulcerative Colitis

Ads

You May Also Like

Cytokinetics Announces New Data Presented at the International Symposium on ALS/MND

Patient Baseline Characteristics from VITALITY-ALS Comparable to BENEFIT-ALS Physician Survey Shows Regional Variability in ...

Nexstim Plc pre-close business update

  Press release, Helsinki, 22 December 2016, at 12pm Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" ...

BeiGene Receives Approval to Initiate Clinical Trials in China with PD-1 Antibody BGB-A317

BEIJING, Sept. 11, 2016 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a clinical-stage biopharmaceutical company ...